申请人:Gilead Sciences, Inc.
公开号:US10246486B2
公开(公告)日:2019-04-02
Provided are compounds of Formula I:
and pharmaceutically acceptable salts and esters thereof. The compounds, compositions, and methods provided are useful for the treatment of virus infections, particularly hepatitis C infections.
提供的是式 I 的化合物:
及其药学上可接受的盐类和酯类。所提供的化合物、组合物和方法可用于治疗病毒感染,尤其是丙型肝炎感染。